about
Low-temperature 1H-NMR spectroscopic study of doxorubicin influence on the hydrated properties of nanosilica modified by DNA.C60 fullerene as synergistic agent in tumor-inhibitory Doxorubicin treatment.Using water-soluble C60 fullerenes in anticancer therapy.Structure and Thermal Stability of Co- and Fe - Intercalated Double Silicene Layers.Structure of Biocompatible Coatings Produced from Hydroxyapatite Nanoparticles by Detonation Spraying.Complex of C60 Fullerene with Doxorubicin as a Promising Agent in Antitumor Therapy.Thermodynamic Complexing of Monocyclopentadienylferrum (II) Intercalates with Double-Walled Carbon Nanotubes.Comparative Analysis of the Antineoplastic Activity of C60 Fullerene with 5-Fluorouracil and Pyrrole Derivative In Vivo.C60 fullerene as promising therapeutic agent for correcting and preventing skeletal muscle fatigue.C60 Fullerene as Promising Therapeutic Agent for the Prevention and Correction of Skeletal Muscle Functioning at Ischemic Injury.Cytotoxic Effects of Dimorfolido-N-Trichloroacetylphosphorylamide and Dimorfolido-N-Benzoylphosphorylamide in Combination with C60 Fullerene on Leukemic Cells and Docking Study of Their Interaction with DNA.Effect of iron-doped multi-walled carbon nanotubes on lipid model and cellular plasma membranes.Using C60 fullerenes for photodynamic inactivation of mosquito iridescent viruses.Comparative study of membranotropic action of single- and multi-walled carbon nanotubes.Magnetometric Studies of Catalyst Refuses in Nanocarbon Materials.C60 fullerenes disrupt cellular signalling leading to TRPC4 and TRPC6 channels opening by the activation of muscarinic receptors and G-proteins in small intestinal smooth muscles.Determination of the equilibrium constant of C60 fullerene binding with drug molecules.Does C60 fullerene act as a transporter of small aromatic molecules?Complexation of C60 fullerene with aromatic drugs.C60 Fullerene Effects on Diphenyl-N-(trichloroacetyl)-amidophosphate Interaction with DNA In Silico and Its Cytotoxic Activity Against Human Leukemic Cell Line In Vitro.C60 fullerene affects elastic properties and osmoregulation reactions of human lymphocytes.Application of C60 Fullerene-Doxorubicin Complex for Tumor Cell Treatment In Vitro and In Vivo.NEW CONFORMATIONAL PROPERTIES OF SH2 DOMAIN BINDING POCKET.C60 Fullerenes Diminish Muscle Fatigue in Rats Comparable to N-acetylcysteine or β-Alanine.Composite material based on hydroxyapatite and multi-walled carbon nanotubes filled by iron: Preparation, properties and drug release abilityEffect of С fullerenes on the intensity of colon damage and hematological signs of ulcerative colitis in ratsEffect of C fullerene nanoparticles on the diet-induced obesity in ratsC fullerene and its nanocomplexes with anticancer drugs modulate circulating phagocyte functions and dramatically increase ROS generation in transformed monocytesC Fullerene Prevents Restraint Stress-Induced Oxidative Disorders in Rat Tissues: Possible Involvement of the Nrf2/ARE-Antioxidant PathwayMonte Carlo simulation of intercalated carbon nanotubesWater-soluble pristine fullerenes C60 increase the specific conductivity and capacity of lipid model membrane and form the channels in cellular plasma membraneCharacterization of C60 fullerene complexation with antibiotic doxorubicinStructural self-organization of C60 and cisplatin in physiological solutionInteraction of C60 fullerene complexed to doxorubicin with model bilipid membranes and its uptake by HeLa cellsEvidence of entropically driven C60 fullerene aggregation in aqueous solutionOn the origin of C₆₀ fullerene solubility in aqueous solutionInterceptor effect of C60 fullerene on the in vitro action of aromatic drug moleculesSingle-walled carbon nanotubes affect the expression of genes associated with immune response in normal human astrocytesWater-Soluble Pristine C60 Fullerenes Inhibit Liver Fibrotic Alteration and Prevent Liver Cirrhosis in RatsImmobilization of cesium from aqueous solution using nanoparticles of synthetic calcium phosphates
P50
Q33810378-E3964276-3B4F-4425-B584-53641F434E71Q34727828-D3F87A60-603B-4FD9-85F4-D4E9BF1654E7Q35673852-90C2765C-819C-4170-B20A-A6D3CAB686F4Q36283265-6072505A-2A03-4331-8FD7-27C47B4A4C7FQ36339088-C49EA494-1422-41A1-B350-BDEB55DD79EFQ36415352-1D1512F3-650F-4793-8C55-54C542EF0953Q36660796-5B80F535-E6FD-4FF9-913C-847B8BA26B95Q37562230-B3BD3D99-2748-474F-9E12-C2F671189207Q37586786-53463650-953D-4F08-BF6E-FDC08F49E109Q37641998-33E956FB-EE5C-4CC5-A213-F2E5D7477B88Q37650538-6B7286BC-52CD-41D8-B10A-4A9C2898D8BAQ39306028-0B7DB0FE-872E-4516-B3D9-C726EE2617D3Q43040154-BC25CF3C-ECAB-40CC-B8F1-A9DDA1B8DD2AQ45167999-F273FFB3-2883-4226-B763-8C7F6B7B1CF8Q46112723-2BADE5B5-222A-4F32-A50A-C15A5A646682Q47292454-7AC42E67-378B-4060-89EC-0D2C4EADD14FQ47965910-D624FC93-E309-4333-A29F-D869C011DC9BQ50138027-C9F17AF7-661B-4949-9882-65C36F91C3C1Q50237683-CF224678-DAE8-4DC7-9B97-CF13DB8AE90DQ52360925-1ED4480F-1953-4C11-8462-717180E06224Q53468716-C789CED0-5C2A-42FD-AD67-7333AD00999CQ53564897-DE9A2B75-1A33-43CF-8FEC-B3E0CA7361C6Q54225089-1EAD63B9-3DF7-4825-A499-F77378D37315Q54963897-9DB3816B-3F80-49CD-BA28-6EDD0921B842Q57023771-B9892F65-A241-4567-8A2E-6272FCD7BBC7Q57023801-539CCE98-02D2-4CBF-BFBB-483BB7B359F4Q58577025-BA1F982E-8DF1-49E0-81C5-75EA911FC60EQ58703382-EC8AA012-ED1D-4B0E-82F8-466EAB1AF729Q59809222-25E8AF1D-C817-49FC-9141-8C935EAF1672Q79222701-16BFBB61-92F6-43AB-8EFC-F4CF222F134DQ84525337-99C6DCBF-C87B-408F-B74F-53EC1D2D8E75Q85633791-4C3ABECB-8EC7-42C2-B63C-84A4F743D07CQ86174033-99980828-D01F-4393-BE35-C1832A9FEF4FQ86881879-6D6681DD-2D1A-48DA-AD4D-13C54A61653EQ87440330-8AA0CAB6-4F39-475C-9FCA-7AB0F9656D5FQ87502811-A5C108BF-968D-4578-99C6-3DBAA40CFBF0Q87713931-DB60F595-C4CB-49A4-8D72-AB2AEF19740CQ89115586-3B67FB1E-EB4F-4197-8ABB-99B4A160BCDFQ90149347-E24D2C1A-B0FE-49AD-A5BA-A891C70820FDQ90458075-7A2A4135-63DD-41CF-9A9E-31B1FE5B2225
P50
description
researcher ORCID ID = 0000-0002-9847-4137
@en
wetenschapper
@nl
name
Yuriy I Prylutskyy
@ast
Yuriy I Prylutskyy
@en
Yuriy I Prylutskyy
@es
Yuriy I Prylutskyy
@nl
type
label
Yuriy I Prylutskyy
@ast
Yuriy I Prylutskyy
@en
Yuriy I Prylutskyy
@es
Yuriy I Prylutskyy
@nl
prefLabel
Yuriy I Prylutskyy
@ast
Yuriy I Prylutskyy
@en
Yuriy I Prylutskyy
@es
Yuriy I Prylutskyy
@nl
P1153
35585493200
P31
P496
0000-0002-9847-4137